PRAC september 2026: veiligheidsonderzoek naar injecteerbare ijzerhoudende geneesmiddelen
Safety Classified by Officially
During its September 2026 meeting, the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency has started the review of injectable iron-containing medicines. The review will assess the risk of low blood phosphate levels and related bone problems with injectable iron medicines. …
This is an extract. The publication continues at the source.
Read the original at the source: https://www.famhp.be/nl/news/prac_september_2026_veiligheidsonderzoek_naar_injecteerbare_ijzerhoudende_geneesmiddelen
Officially imported this from Federal Agency for Medicines and Health Products (FAMHP)’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Federal Agency for Medicines and Health Products (FAMHP) — imported from official source
- Official source
- https://www.famhp.be/en/rss.xml RSS
- Imported
- October 03, 2026 20:37
- Versions
- 1 recorded
- Identity
-
110396 at https://www.famhp.be